Fiduciary Management Inc. WI decreased its stake in shares of Genpact Limited (NYSE:G – Free Report) by 3.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 9,145,480 shares of the business services provider’s stock after selling 349,450 shares during the period. Genpact accounts for about 3.7% of Fiduciary Management Inc. WI’s portfolio, making the stock its 4th largest holding. Fiduciary Management Inc. WI owned 5.19% of Genpact worth $392,798,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently made changes to their positions in the company. SRH Advisors LLC acquired a new position in Genpact in the fourth quarter valued at about $26,000. Atlas Capital Advisors Inc. grew its position in Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider’s stock worth $26,000 after acquiring an additional 216 shares during the last quarter. GeoWealth Management LLC increased its stake in shares of Genpact by 199.0% in the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider’s stock valued at $38,000 after buying an additional 583 shares during the period. Manchester Capital Management LLC acquired a new position in Genpact in the 4th quarter valued at approximately $38,000. Finally, Smartleaf Asset Management LLC raised its position in Genpact by 416.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider’s stock worth $41,000 after purchasing an additional 783 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on G. TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and boosted their price target for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Needham & Company LLC boosted their price objective on Genpact from $55.00 to $65.00 and gave the company a “buy” rating in a report on Friday, February 7th. Jefferies Financial Group upgraded shares of Genpact from a “hold” rating to a “buy” rating and upped their target price for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Finally, Mizuho raised their price objective on Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Six equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $48.44.
Genpact Trading Down 0.4 %
NYSE:G opened at $47.56 on Friday. The firm’s 50 day moving average is $50.52 and its 200 day moving average is $46.04. Genpact Limited has a 12 month low of $30.38 and a 12 month high of $56.76. The stock has a market capitalization of $8.35 billion, a PE ratio of 16.75, a price-to-earnings-growth ratio of 1.84 and a beta of 1.06. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50.
Genpact (NYSE:G – Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. Sell-side analysts expect that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were issued a dividend of $0.17 per share. This is a boost from Genpact’s previous quarterly dividend of $0.15. The ex-dividend date was Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a yield of 1.43%. Genpact’s payout ratio is presently 23.94%.
Insider Buying and Selling
In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the company’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at $15,167,926.94. This represents a 4.20 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.80% of the stock is currently owned by insiders.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading
- Five stocks we like better than Genpact
- Investing In Automotive Stocks
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- 3 Fintech Stocks With Good 2021 Prospects
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.